AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $719,000 | +221.0% | 47,529 | +59.3% | 0.00% | +100.0% |
| Q2 2022 | $224,000 | -55.2% | 29,829 | -45.7% | 0.00% | 0.0% |
| Q1 2022 | $500,000 | +287.6% | 54,967 | +199.4% | 0.00% | – |
| Q4 2021 | $129,000 | -95.5% | 18,358 | -89.9% | 0.00% | -100.0% |
| Q2 2021 | $2,898,000 | -30.4% | 181,018 | -22.3% | 0.01% | -36.4% |
| Q1 2021 | $4,164,000 | +716.5% | 233,029 | +2299.1% | 0.01% | +450.0% |
| Q2 2017 | $510,000 | -95.6% | 9,713 | -96.2% | 0.00% | -94.9% |
| Q1 2017 | $11,482,000 | – | 253,190 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |